PSC Biotech® and BioTechnique® Welcome Laura Wahlen to Team as Microbiology SME, Expanding Microbiology Capabilities
April 30, 2025 | Press Release
York, PA, [April 30, 2025] — PSC Biotech® (“PSC Biotech”) and BioTechnique® LLC (“BioTechnique”) proudly announces the addition of Laura Wahlen to its team as Microbiology Subject Matter Expert (SME). With over 13 years of deep specialization in microbiology and sterility assurance within the pharmaceutical and medical device sectors, Laura’s expertise directly supports the organizations’ commitment to delivering industry-leading aseptic and microbial control solutions.
In her dual role, Laura will lead microbiology strategy and implementation across both PSC Biotech and BioTechnique, strengthening core offerings in contamination control, aseptic validation, and sterilization science. Her extensive background includes hands-on leadership in BSL-2 and BSL-3 laboratories, active participation in ASTM E35.15 Antimicrobial Agents Subcommittee, and the development and validation of microbial methods supporting the full product lifecycle—from R&D through commercial manufacturing. She has also engaged directly with regulatory and notified bodies such as the FDA, Health Canada, and TÜV (The Technical Inspection Association in Germany).
With this exciting new addition, PSC Biotech and BioTechnique are now offering an expanded portfolio of microbiology services, including:
- Disinfectant efficacy studies
- Environmental monitoring programs
- Cleaning validation swab recovery studies
- Endotoxin testing
- Sterility testing
- Terminal sterilization with moist heat
- Vaporized Hydrogen Peroxide (VHP) studies
This expansion positions PSC Biotech and BioTechnique to better serve pharmaceutical and biotech clients seeking rigorous microbiology support for aseptic processing, product development, and regulatory compliance.
About PSC Biotech
PSC Biotech Corporation is a global life sciences consulting, software, and contract services company dedicated to helping bring life-saving pharmaceutical, biotechnology, and medical device products to market. For over two decades, PSC Biotech has partnered with organizations of all sizes—from innovative startups to multinational corporations—to ensure that products are developed, manufactured, and distributed in full compliance with global regulatory standards.
With operations in over 50 countries and a global team of experts spanning North America, Europe, Asia, and the Middle East, PSC Biotech delivers tailored solutions that address every stage of the product lifecycle. From strategic project planning and regulatory consulting to asset management, quality assurance, and manufacturing support, PSC Biotech is committed to providing clients with unparalleled expertise and personalized service.
For more information on PSC Biotech’s capabilities, visit www.biotech.com.
About BioTechnique
BioTechnique, a division of PSC Biotech Corporation, is a full-service Contract Research, Development, and Manufacturing Organization CRDMO specializing in cytotoxic and therapeutic sterile injectable fill-finish services. BioTechnique provides comprehensive support from investigation and clinical stages through commercialization, batch sizes both large and small.
BioTechnique operates a state-of-the-art facility designed to handle a diverse range of pharmaceutical products, including cytotoxic and highly potent compounds, therapeutics, antibody-drug conjugates (ADCs), monoclonal antibodies, suspensions, and vaccines. Supported by an environmentally controlled warehouse and adaptable manufacturing systems, BioTechnique is committed to delivering high-quality fill-finish solutions.
For more information on BioTechnique’s capabilities, visit www.biotechnique.com.
Media Contact:
BioTechnique® Business
Development Group
BTQBD@biotech.com
(717) 377-3547